Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it ...

Request To Download Free Sample of This Strategic Report @- Cardiovascular genetic testing enables clinicians and patients to identify inherited risks for a wide range of cardiac disorders, including ...

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor ...